CHEN Guang-tong, YANG Xue, GE Hong-juan, et al. Biotransformation Optimization of 20()-protopanaxadiol by AS 3.205[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(8): 34-38.
CHEN Guang-tong, YANG Xue, GE Hong-juan, et al. Biotransformation Optimization of 20()-protopanaxadiol by AS 3.205[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(8): 34-38. DOI: 10.13422/j.cnki.syfjx.2015080034.
提高过氧衍生物的产率。方法: 选取总状毛霉Mucor racemosus AS 3.205为转化菌株
从接菌量
底物浓度
转化时间
加样时间
温度
转速等方面对转化条件进行优化。结果: 获得2个20(S)-原人参二醇过氧衍生物
20(S)-原人参二醇为25
26-烯-24(R)过氧羟基-20(S)-原人参二醇和23
24-烯-25过氧羟基-20(S)-原人参二醇;获得了优化的转化工艺
即接种量为10%
底物浓度为0.25 mmol·L-1
加样时间为转种后48 h
培养温度为28 ℃
转化时间为5 d
摇床转速为150 r·min-1。结论: 该方法能简便的获得20(S)-原人参二醇过氧衍生物
采用优化后的转化条件25
26-烯-24(R)过氧羟基-20(S)-原人参二醇和23
24-烯-25过氧羟基-20(S)-原人参二醇的产率均明显增大。
Abstract
Objective: The aim of this study was to provide a new approach to synthesize hydroperoxylated products of 20 (S) -protopanaxadiol
and to optimize the microbial transformation conditions by Mucor racemosus AS 3.205. Method: Biotransformation conditions were optimized by altering several influencing factors. The yields of two hydroperoxylated products of 20 (S) -protopanaxadiol were evaluated. Result: Two metabolites were isolated and identified as 25
26-en-24 (R)-hydroperoxyl-20 (S) -protopanaxadiol and 23
24-en-25-hydroperoxyl-20 (S) -protopanaxadiol. The optimal transformation condition was as following:an inoculation amount at 10%
substrate concentration at 0.25 mmol·L-1
sample injected after inoculated 48 h
transformation time of 5 d
culture temperature at 28 ℃
and shaking speed at 150 r·min-1. Conclusion: Microbial transformation system by M. racemosus AS 3.205 can be used to obtain hydroperoxylated products of 20 (S) -protopanaxadiol. The yields of two hydroperoxylated products could be greatly increased under the optimized condition.